Skip to main content
. 2017 Feb 22;39(4):819–830. doi: 10.3892/ijmm.2017.2904

Figure 1.

Figure 1

(A) Chemical structure of naringin (Nar). (B) Pre-treatment with Nar at various concentrations (200, 600 and 1,000 ng/ml) and for different periods of time (0.5, 1 and 2 h) mitigated lipopolysaccharide (LPS)-induced cell death. (C) Safe dose of Nar to maintain cell viability. (D) Dose- and time-dependent effects of LPS on cell viability. Data are presented as the means ± SD (n=5 treatment groups). *p<0.05 and **p<0.01 compared with the LPS group.